Teledermatology for suspected skin cancer costs more than usual care—but it speeds up the time to clinical resolution by nearly a month, according to a study published online May 9 in JAMA Dermatology.

CMS Administrator Seema Verma, MPH, spoke at a May 15 Washington Post event focused on health policy, offering some hints on where her agency’s Medicaid and Affordable Care Act (ACA) regulations may be headed.

A team of U.S. researchers has found a radiomics approach to analyze CT images of lung cancers that may eliminate false positives during cancer screening. It could potentially minimize morbidity, mortality and healthcare costs.

Technology out of Vanderbilt University and Mayo Clinic could be cutting false positive rates in CT-based lung cancer screenings, researchers announced in PLOS One this week.

Radiology department employees are expected to report safety concerns, ensuring that their patients are cared for in the safest environment possible. However, according to a new study published in Radiology, employees don’t always report such issues.

A combination of positive results of flutemetamol F 18–labeled PET data, low hippocampal volume and cognitive status is associated with a higher risk of progression from amnestic mild cognitive impairment (aMCI) to Alzheimer's disease within three years.

Millennials growing up in an evolving world of digital connection might be drawn to the high-tech nature of radiology, but those same prospective physicians should be wary of their bedside manner, according to one Arizona clinician.

Researchers have identified a genetic variant that may predispose individuals to alcoholic cardiomyopathy (ACM), possibly opening the door for genetic testing and familial evaluation.

First lady Melania Trump underwent an image-guided embolization treatment for a benign kidney condition earlier this week, casting a sudden spotlight on the world of interventional radiology.

A prospective comparison study of two PET tracers found 18F-FDG could provide valuable measures of activity in bone-dominant (BD) metastatic breast cancer (MBC) patients, while also predicting responses to therapy.